CONCERT PHARMACEUTICALS INC - COM (CNCE) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2023

Type / Class
Equity / COM
Symbol
CNCE
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of CONCERT PHARMACEUTICALS INC - COM (CNCE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q2 0 $0 -$3,194,016 0
2023 Q1 0 $0 -$207,204,555 0
2022 Q4 35,478,572 $207,206,862 +$5,367,605 $5.84 85
2022 Q3 33,909,062 $227,190,055 +$25,572,223 $6.70 80
2022 Q2 30,057,508 $126,536,488 +$54,214,522 $4.21 65
2022 Q1 17,195,889 $57,971,038 -$2,989,026 $3.37 49
2021 Q4 18,123,478 $57,090,282 +$1,581,040 $3.15 48
2021 Q3 17,450,087 $57,085,353 -$2,966,448 $3.27 59
2021 Q2 18,306,969 $77,246,409 -$11,016,846 $4.22 77
2021 Q1 20,764,099 $103,606,919 -$59,314,365 $4.99 88
2020 Q4 23,835,655 $301,314,612 +$29,687,923 $12.64 97
2020 Q3 21,461,846 $210,737,067 -$468,106 $9.82 89
2020 Q2 21,504,122 $213,952,717 +$8,018,858 $9.95 87
2020 Q1 19,762,999 $175,238,641 +$35,210,718 $8.84 78
2019 Q4 15,772,561 $145,496,081 +$1,323,762 $9.22 76
2019 Q3 15,717,426 $92,427,294 -$20,720,297 $5.88 78
2019 Q2 16,811,043 $201,688,264 -$6,370,921 $12.00 83
2019 Q1 17,767,677 $214,451,970 -$334,230 $12.07 89
2018 Q4 17,744,500 $221,990,224 +$4,188,445 $12.55 90
2018 Q3 17,175,623 $254,879,645 -$699,348 $14.84 109
2018 Q2 17,221,824 $289,880,623 -$10,215,488 $16.83 119
2018 Q1 17,444,880 $399,475,184 +$12,479,330 $22.90 122
2017 Q4 16,346,337 $422,926,796 +$46,299,585 $25.87 113
2017 Q3 14,868,974 $219,315,765 +$13,878,644 $14.75 79
2017 Q2 13,981,045 $195,036,250 +$276,329 $13.95 78
2017 Q1 14,025,662 $239,266,546 +$48,442,882 $17.06 85
2016 Q4 12,947,660 $133,194,974 -$1,600,433 $10.29 88
2016 Q3 13,176,966 $133,211,583 -$5,534,956 $10.11 93
2016 Q2 13,705,095 $153,952,654 -$3,270,389 $11.23 96
2016 Q1 13,881,286 $189,585,337 +$2,293,321 $13.66 95
2015 Q4 13,531,709 $256,715,814 -$7,200,029 $18.97 91
2015 Q3 13,729,106 $257,672,989 +$45,379,519 $18.77 88
2015 Q2 11,604,429 $172,783,263 +$23,490,378 $14.89 66
2015 Q1 10,154,779 $153,685,000 +$38,639,887 $15.15 66
2014 Q4 7,421,914 $98,820,000 +$12,021,505 $13.32 53
2014 Q3 6,547,114 $82,566,000 +$16,992,860 $12.61 50
2014 Q2 5,745,508 $58,024,882 -$3,789,515 $10.10 49
2014 Q1 5,864,525 $78,748,000 +$77,941,000 $13.45 48